Skip to main content
Top
Published in: European Journal of Epidemiology 9/2007

01-09-2007 | Cancer

Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge database

Authors: Zoe Uhry, Marc Colonna, Laurent Remontet, Pascale Grosclaude, Nicolas Carré, Chantal Marie Couris, Michel Velten

Published in: European Journal of Epidemiology | Issue 9/2007

Login to get access

Abstract

Objective

As in many countries, cancer registries cover only part of the population in France. Incidence/mortality ratio observed in registries is usually extrapolated to produce national estimates of cancer incidence. District-level estimates are not currently available. For cancer sites such as thyroid, the incidence/mortality ratio widely varies between districts, and alternative indicators must be explored. This study aims to produce national and district-level estimations of thyroid cancer incidence in France, using the ratio between incidence and hospital-based incidence.

Methods

Analyses concerned population living in France and aged over 20, for the period 1998–2000. For each sex, number of incident cases were analysed according to number of surgery admissions for thyroid cancer (Poisson model) in the districts covered by a registry. Age was included in the model as fixed effect and district as random effect. The model’s ability to predict incidence was tested through cross-validation. The model was then extrapolated to produce national incidence estimations, and for women, district-level estimations.

Results

The national estimations of incidence rate age-standardised on the world population were 3.1 [95% prediction interval: 2.8–3.4] for men and 10.6 [9.8–11.4] for women, corresponding respectively to 1,148 [1,042–1,264] and 4,104 [3,817–4,413] annual new cases. For women, district-level incidence rates presented wide geographical variations, ranging broadly from 5 to 20 per 100,000. These estimations were quite imprecise, but their imprecision was smaller than the extent of geographical disparities.

Conclusion

National incidence estimations obtained are relatively precise. District-level estimations in women are imprecise and should be treated carefully. They are informative though regarding the extent of geographical disparities. The approach can be useful to improve national incidence estimates and to produce district-level estimates for cancer sites presenting a high variability of the incidence/mortality ratio.
Literature
1.
go back to reference Remontet L, Esteve J, Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978–2000. Rev Epidemiol Sante Publique 2003;51:3–30.PubMed Remontet L, Esteve J, Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978–2000. Rev Epidemiol Sante Publique 2003;51:3–30.PubMed
2.
go back to reference Remontet L, Buemi A, Velten M, Jougla E, Esteve J. Évolution de l’incidence et de la mortalité par cancer en France de 1978 à 2000 [Rapport]. Francim/Hôpitaux de Lyon/Inserm/Institut de veille sanitaire. Paris, septembre 2003. Remontet L, Buemi A, Velten M, Jougla E, Esteve J. Évolution de l’incidence et de la mortalité par cancer en France de 1978 à 2000 [Rapport]. Francim/Hôpitaux de Lyon/Inserm/Institut de veille sanitaire. Paris, septembre 2003.
3.
go back to reference Colonna M, Grosclaude P, Remontet L, et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Eur J Cancer 2002;38:1762–8.PubMedCrossRef Colonna M, Grosclaude P, Remontet L, et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Eur J Cancer 2002;38:1762–8.PubMedCrossRef
4.
go back to reference Montanaro F, Pury P, Bordoni A, Lutz JM. Unexpected additional increase of thyroid cancer incidence among recent birth cohort in Switzerland. Eur J Cancer Prev 2006;15(2):178–86.PubMedCrossRef Montanaro F, Pury P, Bordoni A, Lutz JM. Unexpected additional increase of thyroid cancer incidence among recent birth cohort in Switzerland. Eur J Cancer Prev 2006;15(2):178–86.PubMedCrossRef
5.
go back to reference Pettersson B, Adami HO, Wilander E, Coleman MP. Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type. Int J Cancer 1991;48:28–33.PubMedCrossRef Pettersson B, Adami HO, Wilander E, Coleman MP. Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type. Int J Cancer 1991;48:28–33.PubMedCrossRef
6.
go back to reference Akslen LA, Haldorsen T, Thoresen SO, Glattre E. Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period. Int J Cancer 1993;53:183–7.PubMedCrossRef Akslen LA, Haldorsen T, Thoresen SO, Glattre E. Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period. Int J Cancer 1993;53:183–7.PubMedCrossRef
7.
go back to reference Dos Santos Silva I, Swerdlow AJ. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 1993;67:330–40.PubMed Dos Santos Silva I, Swerdlow AJ. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 1993;67:330–40.PubMed
8.
go back to reference Zheng T, Holford TF, Chen Y, et al. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935–1992. Int J Cancer 1996;67(4):504–9.PubMedCrossRef Zheng T, Holford TF, Chen Y, et al. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935–1992. Int J Cancer 1996;67(4):504–9.PubMedCrossRef
9.
go back to reference Liu S, Semenciw R, Ugnat AM, Mao Y. Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer 2001;85(9):1335–9.PubMedCrossRef Liu S, Semenciw R, Ugnat AM, Mao Y. Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer 2001;85(9):1335–9.PubMedCrossRef
10.
go back to reference Leenhardt L, Bernier MO, Boin-Pineau MH, et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 2004;150:133–9.PubMedCrossRef Leenhardt L, Bernier MO, Boin-Pineau MH, et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 2004;150:133–9.PubMedCrossRef
11.
go back to reference Carré N, Uhry Z, Velten M, et al. Predictive value and sensibility of hospital discharge system (PMSI) compared to cancer registries for thyroid cancer (1999–2000). Rev Epidemiol Sante Publique 2006;54:367–76.PubMed Carré N, Uhry Z, Velten M, et al. Predictive value and sensibility of hospital discharge system (PMSI) compared to cancer registries for thyroid cancer (1999–2000). Rev Epidemiol Sante Publique 2006;54:367–76.PubMed
12.
go back to reference Wolfinger R, O’Connell M. Generalized linear mixed models: a pseudo-likelihood approach. J Statist Comput Simul 1993;48:233–43.CrossRef Wolfinger R, O’Connell M. Generalized linear mixed models: a pseudo-likelihood approach. J Statist Comput Simul 1993;48:233–43.CrossRef
13.
go back to reference Kotz S, Johnson NL, Read CB. Encyclopedia of statistical sciences. New York: John Wiley; 1988. p. 646–7. Kotz S, Johnson NL, Read CB. Encyclopedia of statistical sciences. New York: John Wiley; 1988. p. 646–7.
14.
go back to reference Hakulinen T, Dyba T. Precision of incidence predictions based on Poisson distributed observations. Stat Med 1994;13:1513–23.PubMedCrossRef Hakulinen T, Dyba T. Precision of incidence predictions based on Poisson distributed observations. Stat Med 1994;13:1513–23.PubMedCrossRef
15.
go back to reference Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents, vol. VIII. IARC CancerBase No. 7, Lyon, 2005. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents, vol. VIII. IARC CancerBase No. 7, Lyon, 2005.
16.
go back to reference Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer statistics review, 1975–2002. National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2002/, based on November 2004 SEER data submission, posted to the SEER web site 2005. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer statistics review, 1975–2002. National Cancer Institute, Bethesda, MD, http://​seer.​cancer.​gov/​csr/​1975_​2002/​, based on November 2004 SEER data submission, posted to the SEER web site 2005.
17.
go back to reference Hundahl S, Fleming I, Fremgen A, Menck H. A national cancer data base report on 53856 cases of thyroid carcinoma treated in US: 1985–1995. Cancer 1998;83:2638–48.PubMedCrossRef Hundahl S, Fleming I, Fremgen A, Menck H. A national cancer data base report on 53856 cases of thyroid carcinoma treated in US: 1985–1995. Cancer 1998;83:2638–48.PubMedCrossRef
18.
go back to reference Leenhardt L, Grosclaude P, Chérié-Challine L, et al. Recommandations pour la mise en place d’un dispositif de surveillance épidémiologique nationale des cancers thyroïdiens [Rapport]. Institut de veille sanitaire, Paris, Octobre 2002. Leenhardt L, Grosclaude P, Chérié-Challine L, et al. Recommandations pour la mise en place d’un dispositif de surveillance épidémiologique nationale des cancers thyroïdiens [Rapport]. Institut de veille sanitaire, Paris, Octobre 2002.
19.
go back to reference Clayton DG. Generalized linear mixed models. In: Gilks WR, Richardson S, Spiegelhalter DJ, editors. Markov chain Monte Carlo in practice. Chapman & Hall; 1996. p. 275–301. Clayton DG. Generalized linear mixed models. In: Gilks WR, Richardson S, Spiegelhalter DJ, editors. Markov chain Monte Carlo in practice. Chapman & Hall; 1996. p. 275–301.
20.
go back to reference Couris CM, Colin C, Rabilloud M, Schott AM, Ecochard R. Method of correction to assess the number of hospitalized incident breast cancer cases based on claims databases. J Clin Epidemiol 2002;55:386–91.PubMedCrossRef Couris CM, Colin C, Rabilloud M, Schott AM, Ecochard R. Method of correction to assess the number of hospitalized incident breast cancer cases based on claims databases. J Clin Epidemiol 2002;55:386–91.PubMedCrossRef
21.
go back to reference Couris CM, Rabilloud M, Colin C, Ecochard R. Two-phase study to assess the number of cases based on claims databases: characteristics of the validation data set. Methods Inf Med 2002;41(4):349–56.PubMed Couris CM, Rabilloud M, Colin C, Ecochard R. Two-phase study to assess the number of cases based on claims databases: characteristics of the validation data set. Methods Inf Med 2002;41(4):349–56.PubMed
22.
go back to reference Colonna M, Grosclaude P, Faivre J, et al. Cancer registry data based estimation of regional cancer incidence: application to breast and colorectal cancer in French administrative regions. J Epidemiol Community Health 1999;53:558–64.PubMedCrossRef Colonna M, Grosclaude P, Faivre J, et al. Cancer registry data based estimation of regional cancer incidence: application to breast and colorectal cancer in French administrative regions. J Epidemiol Community Health 1999;53:558–64.PubMedCrossRef
23.
go back to reference Pickle L, Feuer E, Edwards B. US predicted cancer incidence, 1999: complete maps by county and state from spatial projection models. NCI Cancer Surveillance Monograph Series, Number 5. Bethesda, MD: National Cancer Institute, 2003. NIH Publication No 03-5435. http://srab.cancer.gov/incidence/PCIMono_full.pdf. Pickle L, Feuer E, Edwards B. US predicted cancer incidence, 1999: complete maps by county and state from spatial projection models. NCI Cancer Surveillance Monograph Series, Number 5. Bethesda, MD: National Cancer Institute, 2003. NIH Publication No 03-5435. http://​srab.​cancer.​gov/​incidence/​PCIMono_​full.​pdf.​
Metadata
Title
Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge database
Authors
Zoe Uhry
Marc Colonna
Laurent Remontet
Pascale Grosclaude
Nicolas Carré
Chantal Marie Couris
Michel Velten
Publication date
01-09-2007
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 9/2007
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-007-9158-6

Other articles of this Issue 9/2007

European Journal of Epidemiology 9/2007 Go to the issue